An interventional study of Splint and Splint with strengthening exercises in Thumb Osteoarthritis and First Dorsal Interosseous Strengthening, sponsored by Massachusetts General Hospital. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-10.
Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Osteoarthritis by Massachusetts General Hospital — 3 open to participants now, 4 under way, 1 of them phase 3. Osteoarthritis · Massachusetts General Hospital.
Among the 13 studies in Osteoarthritis by Massachusetts General Hospital, this one is the 2nd largest by enrollment of the 10 interventional ones that give a count, is one of 3 that started in 2016, is one of 8 with no phase, and was the 9th registered.
2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.
Browse Osteoarthritis studies →3 of the 13 studies in Osteoarthritis by Massachusetts General Hospital are open now, in 1 country. Recruiting first, the newest first:
Massachusetts General Hospital · Sites in United States
Ages 18+
Massachusetts General Hospital · Sites in United States
Ages 18+
Massachusetts General Hospital · Sites in United States
Ages 40+
By country, each count listing its studies:
Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 3 started in 2016.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 160 is above the median of 80 across 2,242 interventional studies indexed under Osteoarthritis.
Median enrollment 85 across the 10 interventional studies, 400 across the 3 observational. Of the 6 that completed or were terminated, 6 (100%) have results posted.
This tab as a report to print or save as PDF → With an account.
Massachusetts General Hospital is the lead sponsor of 2,591 studies on the registry; 445 are open to participants now.
Of its 224 completed or terminated interventional studies of FDA-regulated products, 168 (75%) have results posted.
1 of the studies in Osteoarthritis by Massachusetts General Hospital that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06003101Phase 3Massachusetts General HospitalEffect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies | 2027-08-30 |
Add it to your calendar (.ics) → With an account.
Among the 13 studies in Osteoarthritis by Massachusetts General Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
To determine the effect of first dorsal interosseus (FDI) strengthening in patients with thumb carpometacarpal (CMC) osteoarthritis.
Thumb CMC osteoarthritis is a normal part of aging. Most patients are able to adapt to symptoms of pain and disability, other patients might benefit from non-operative interventions; e.g. splinting, corticosteroid injections, pain medication, and multiple hand exercises.
The dorsal ligament complex is one of the components for stability of the thumb CMC joint. These ligaments specifically create stability for pinch and grip during the final phase of opposition. Both, the opponens pollicis (OP) and the first dorsal interosseous (FDI) play a key role in centralizing the metacarpal on the trapezium. A retrospective study showed that a dynamic stability modeled approach, including targeting the FDI, reduced pain and improved function in patients with thumb CMC osteoarthritis. Recently, another study demonstrated that reduction of radial subluxation - the thumb metacarpal versus the trapezium CMC joint - was achieved by contraction of the dynamic stabilizers of the healthy hand, specifically with the focus on the FDI.
More clinical research is needed to determine if there are efficacious (effective and low-cost) evidence-based exercise programs for pain reduction and functional improvement in patients with thumb CMC osteoarthritis. The investigators are interested in the effect of FDI strengthening in patients with thumb CMC osteoarthritis. Therefore, the investigators hypothesized that there is no difference in the change of lateral pinch strength at 12 weeks between patients treated with a splint versus patients treated with a splint and FDI strengthening for thumb CMC osteoarthritis. We also tested the same hypothesis for 3-point chuck strength, VAS for pain, and PROMIS Upper Extremity CAT.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subjects with carpometacarpal (CMC) osteoarthritis treated by splinting of their thumb.
Device: Splint
Subjects with carpometacarpal (CMC) osteoarthritis treated by splinting of their thumb combined with first dorsal interosseous (FDI) strengthening stabilization exercises.
Device: Splint with strengthening exercises
Subjects will use a splint custom-made by Massachusetts General Hospital Occupational Therapists as part of standard care for treatment of carpometacarpal (CMC) osteoarthritis.
Subjects will use a splint custom-made by Massachusetts General Hospital Occupational Therapists as part of standard care for treatment of carpometacarpal (CMC) osteoarthritis and will also be taught two first dorsal interosseous (FDI) strengthening exercises.
Difference in Lateral Pinch Strength at 12 Weeks
The investigators will measure lateral pinch strength by placing a pinch meter between the pad of the thumb and lateral surface of the index finger. The investigators will compare the change in lateral pinch strength between the two cohorts after 12 weeks of treatment.
Time frame: At enrollment and 12 week follow up
Difference in 3-point Chuck Strength at 12 Weeks
Investigators will measure the pinch strength by placing a pinch meter between the pad of the thumb and pad of the index and middle finger. The investigators will compare the change in 3 point chuck strength between the two cohorts after 12 weeks of treatment.
Time frame: At enrollment and 12 week follow up
Visual Analog Scale (VAS) for Pain
The Visual Analog Scale for Pain measures the amount of pain on a scale from 0, no pain, to 10, worst possible pain. The investigators will compare the change in pain between the two cohorts after 12 weeks of treatment.
Time frame: At enrollment and 12 week follow up
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity Computer Adaptive Test (CAT) at 12 Weeks
A computerized assessment of depression measured at enrollment. The average T score of the U.S. population is 50 with a standard deviation of 10, so the T score reported compares the study population to the U.S. population, where a T score greater than 50 is worse than the average and a T score less than 50 is better than the average. The investigators will compare the change in PROMIS Upper Extremity between the two cohorts after 12 weeks of treatment.
Time frame: At Enrollment and 12 week follow up
| Milestone | Splint Only | Splint With First Dorsal Interosseous (FDI) Strengthening |
|---|---|---|
| Started | 80 | 80 |
| Completed | 44 | 43 |
| Not completed | 36 | 37 |
Investigators will measure the pinch strength by placing a pinch meter between the pad of the thumb and pad of the index and middle finger. The investigators will compare the change in 3 point chuck strength between the two cohorts after 12 weeks of treatment.
| pounds | Splint Only | Splint With First Dorsal Interosseous (FDI) Strengthening |
|---|---|---|
| Difference in 3-point Chuck Strength at 12 Weeks | 0.708 ± 2.600 | 1.103 ± 2.024 |
The investigators will measure lateral pinch strength by placing a pinch meter between the pad of the thumb and lateral surface of the index finger. The investigators will compare the change in lateral pinch strength between the two cohorts after 12 weeks of treatment.
| pounds | Splint Only | Splint With First Dorsal Interosseous (FDI) Strengthening |
|---|---|---|
| Difference in Lateral Pinch Strength at 12 Weeks | 0.458 ± 2.843 | 1.138 ± 3.136 |
The Visual Analog Scale for Pain measures the amount of pain on a scale from 0, no pain, to 10, worst possible pain. The investigators will compare the change in pain between the two cohorts after 12 weeks of treatment.
| points on a scale | Splint Only | Splint With First Dorsal Interosseous (FDI) Strengthening |
|---|---|---|
| Visual Analog Scale (VAS) for Pain | -0.89 ± 2.093 | -0.875 ± 2.584 |
A computerized assessment of depression measured at enrollment. The average T score of the U.S. population is 50 with a standard deviation of 10, so the T score reported compares the study population to the U.S. population, where a T score greater than 50 is worse than the average and a T score less than 50 is better than the average. The investigators will compare the change in PROMIS Upper Extremity between the two cohorts after 12 weeks of treatment.
| T-score | Splint Only | Splint With First Dorsal Interosseous (FDI) Strengthening |
|---|---|---|
| Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity Computer Adaptive Test (CAT) at 12 Weeks | 0.739 ± 7.234 | 1.202 ± 5.704 |
Collected over Adverse event data were collected throughout the study participation period, from enrollment through the 12-week follow-up period (11-13 weeks after enrollment).. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Splint Only | 0/80 (0%) | 0/80 (0%) | 0/80 (0%) |
| Splint With First Dorsal Interosseous (FDI) Strengthening | 0/80 (0%) | 0/80 (0%) | 0/80 (0%) |
| Age, Continuous(years) | Splint Only | Splint With First Dorsal Interosseous (FDI) Strengthening | Total |
|---|---|---|---|
| Median | 61 (56 to 71) | 67 (58 to 72) | 64 (56 to 72) |
| Sex: Female, Male(Participants) | Splint Only | Splint With First Dorsal Interosseous (FDI) Strengthening | Total |
|---|---|---|---|
| Female | 30 | 24 | 54 |
| Male | 14 | 19 | 33 |
| Race (NIH/OMB)(Participants) | Splint Only | Splint With First Dorsal Interosseous (FDI) Strengthening | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 2 | 1 | 3 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 1 | 0 | 1 |
| White | 39 | 40 | 79 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 2 | 2 | 4 |
| Region of Enrollment(participants) | Splint Only | Splint With First Dorsal Interosseous (FDI) Strengthening | Total |
|---|---|---|---|
| United States | 44 | 43 | 87 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Dec 2016 to primary completion in Jun 2025, 102 months.
Results were first posted in Nov 2026, 1 year 5 months after primary completion.
Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's 102 months is above that.
Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Massachusetts General Hospital →